conjugated to glycine, or taurine when the glycine conjugates predominate (Hofmann, 1984) . Conjugation of bile acids to glycine and taurine is one mechanism by which an organism can decrease the hydrophobicity of a bile acid (Martinez-Diez et al., 2000; Rust et al., 2000) . The conjugation renders the molecules less cytotoxic at physiological concentrations (Patel et al., 1994) . Numerous studies have shown that elevated concentrations of bile acid within the liver induce hepatocyte apoptosis. This provides a cellular mechanism for bile acidmediated liver injury (Patel et al., 1998) . Bile acid hydrophobicity is correlated with induction of apoptosis and/ or growth arrest (Powell et al., 2001) . Highly hydrophobic bile acids, such as DCA and CDCA, are able to induce apoptosis rapidly.
Recently, it was reported that several synthetic bile acids induced apoptosis in human hepatocellular carcinoma cells, human breast carcinoma cells, and human leukemic T cells Park et al., 1997; Im et al., 1999; Im et al., 2001) , and inhibited angiogenesis in human hepatocellular carcinoma cells . Moreover, UDCA and its synthetic derivatives, HS-1030 and HS-1183, inhibited SV40 DNA replication, and predominantly inhibited the initiation stage of DNA replication .
In this review, we will describe the biological activity of natural bile acids and synthetic derivatives, focusing on their role as mediators of apoptosis. A discussion of the biochemical and cellular effects of synthetic bile acids will follow an introduction to the induction of apoptosis by natural bile acids. We will then discuss inducers, targets, and the mechanism of action of natural and synthetic bile acids. The chapter will conclude with a discussion on the implications of the results, and a discussion on the potential therapeutic possibilities that arise from modulation of the apoptotic process.
Natural bile acids as inducers of apoptosis
Natural bile salt-induced apoptosis is a tissue-and diseasespecific process (Blake et al., 1998) . Hepatocytes, cholangiocytes, and ileal enterocytes are the only cells in the human body that can transport natural bile salts intracellularly. Different natural bile acids exhibit distinct biological effects in vivo and in vitro. Recent studies have shown that bile acids can affect intracellular signaling and gene expression, which may ultimately lead to alterations in cell growth and tumorigenesis (Qiao et al., 2001a) . Several growth regulatory genes, such as cyclooxygenase-2 (Zhang et al., 1998) , GADD153 (Zheng et al., 1996) and c-myc (Takai et al., 1986; Porsch Hallstrom et al., 1991) , as well as transcription factors such as activator protein-1 (AP-1) (Qiao et al., 2000) and NF-κB , are activated by bile acids.
Primary bile acid, hydrophobic CA, has no discernible effect on the human colon cancer cells, and little or no activity is provided if it is not metabolized to DCA (Martinez et al., 1998) . In hepatic stellate cells, CA induces egr and fos, early response genes in the requirement of protein kinase C (PKC) *To whom correspondence should be addressed. Tel: 82-51-5102801; Fax: 82-51-5136754 E-mail: nadkim@pusan.ac.kr α and/or PKC δ. PKC is also known as the only cytoplasmic signaling molecule that responds to bile acids (Brady et al., 1996) . Taurocholic acid is a water-soluble major secondary CA. It can activate mitogen-activated protein kinase (MAPK) in hepatic stellate cells (Brady et al., 1996) . Bile acids also activate the major cytoplasmic signaling kinases of the stellate cells, which seem to regulate many plasma-membrane receptor-driven cascades that are associated with tyrosine kinase, or GTP-binding protein receptors (Hunter, 1995; Marshall, 1995; Brady et al., 1996) .
CDCA, a primary bile acid, acts as a tumor promoter in animal models, enhances cell transformation in vitro, and induces apoptosis in several different tumor cell lines (Martinez et al., 1998; Faubion et al., 1999; Mahmoud et al., 1999; Sodeman et al., 2000) . Several laboratories identified the farnesoid X receptor (FXR) as a CDCA receptor, and PKC was suggested as a signaling mediator of CDCA (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999; Rust et al., 2000; Song et al., 2001) .
Various activities of CDCA on cells have also been reported. Hydrophobic CDCA is known as a tumor promoter in certain experimental systems. It also enhances cell transformation in vitro and apoptosis in several different tumor cell lines, such as HCT116 and HT29 human colon cancer cells (Brady et al., 1996; Martinez et al., 1998) . During the apoptotic process of HCT116, the caspase-3 activity was stimulated, and the caspase-3 activity and apoptosis could be suppressed by bcl-2. Noticeably, the over-expression of bcl-2 or the inhibition of PKC activity caused the mode of cell death to switch from apoptosis to necrosis (LaRue et al., 2000) . CDCA also induced AP-1 activity in human colon adenocarcinoma cells (Hirano et al., 1996; Glinghammar et al., 1999) and in hepatic stellate cells (Brady et al., 1996) . In human esophageal adenocarcinoma cells, CDCA induced the cyclooxygenase-2 expression (Zhang et al., 1998) . In human colon cancer Caco-2 cells, it induced the c-fos gene expression through PKC activation (Di Toro et al., 2000) . The ability of bile acids to induce apoptosis, as well as stimulate proto-oncogenes such as cyclooxygenase-2, c-myc and AP-1, suggests that bile acids may exert their tumor-promoting activity by modulating intracellular signaling and gene expression. This will consequently change cell growth and tumorigenesis (Zhang et al., 1998; Qiao et al., 2001a; Debruyne et al., 2001) .
Glycochenodeoxycholic acid (GCDC), a toxic, dihydroxy, and hydrophobic bile acid, induced Fas oligomerization and activated caspase-8, which resulted in apoptosis, independently of Fas ligand (Faubion et al., 1999) . The taurine conjugate of CDCA, taurochenodeoxycholate (TCDC), activates the phosphatidylinositol 3-kinase (PI3K), a potent activator of survival signals. This raises the possibility that nontoxic and hydrophobic bile acids do not trigger apoptosis, because they activate a PI3K-dependent survival signaling pathway (Yao and Cooper, 1995; Misra et al., 1998; Rust et al., 2000) . TCDC also activated NF-κB in a PI3K-and PKCξ-dependent manner. This process could contribute to the reduction of cytotoxicity by TCDC (Rust et al., 2000) .
Secondary bile acid, DCA, had a similar activity in apoptosis induction with a CDCA (Martinez et al., 1998; Zhang et al., 1998; Glinghammar et al., 1999; Di Toro et al., 2000) . DCA induced DNA damage and apoptosis in human colon epithelial cells in a p53-independent manner (Powolny et al., 2001) . Also, DCA could suppress p53 by stimulating the proteosome-mediated p53 protein degradation (Qiao et al., 2001a) . Interestingly, apoptosis induction by DCA could be suppressed by inhibiting PKC activity with calphostin C (Martinez et al., 1998) , and also be modulated by the extracellular signal-regulated kinase (ERK) (Qiao et al., 2001a) . DCA also caused ligand-independent activation of both the epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes via the MAPK signaling pathway (Qiao et al., 2001b) .
Glycodeoxycholic acid (GDCA) induced apoptosis in hepatocytes by a mechanism that is associated with DNA cleavage by endonucleases (Kwo et al., 1995) , and induction of the TRAIL-receptor 2/DR5 expression (Higuchi et al., 2001) . In addition to this, the overexpression of PKCξ blocked the GCDA-induced apoptosis (Rust et al., 2000) .
LCA, hydrophobic secondary bile acid, induced AP-1 activity in both HT29 and HCT116 (Glinghammar et al., 1999) , and induced egr in hepatic stellate cells with the activation of MAPK (Brady et al., 1996) . LCA also induced the c-fos gene expression through PKC in human colon cancer Caco-2 cells (Di Toro et al., 2000) .
A representative secondary bile acid, UDCA, is known as a chemopreventive agent (Earnest et al., 1994) by inhibiting cell proliferation without inducing apoptosis (Martinez et al., 1998) . UDCA inhibited progression through the cell cycle, and caused cells to become blocked in the G1 phase of the cell cycle (Martinez et al., 1998) . UDCA also prevented bilirubininduced apoptosis that is aggravated by CDCA in cultured rat neural cells (Silva et al., 2001) . Hydrophilic UDCA and its taurine and glycine conjugates protect cells against apoptosis that is induced by several hydrophobic bile acids (Heuman et al., 1991; Heuman et al., 1994) . This protective effect is due to the direct prevention of mitochondrial membrane perturbation (Rodrigues et al., 1998) . Figure 1 shows a graphical representation of the CDCA and UDCA structures and where modifications occurred. A new glycine methyl ester conjugate of UDCA, HS-1030, induced apoptosis in HepG2 human hepatocellular carcinoma cells and MCF-7 human breast carcinoma cells Park et al., 1997; Im et al., 1999) . It had little cytotoxic effect in the immortalized human breast epithelial cell line MCF-10A (Im, E.O. & Kim, N.D., unpublished data) . HS-1030 also showed inhibitory effects on embryonic angiogenesis in chick embryo chorioallantoic membranes that showed antiangiogenic activity, and exhibited no cytotoxic effect on the calf pulmonary artery endothelial (CPAE) cells . Additionally, HS-1030 and L-phenylalanine benzyl ester conjugate of UDCA, HS-1183, inhibited SV40 DNA replication, and predominantly inhibited the initiation stage of DNA relication . The L-phenyl alanine benzyl ester conjugate (HS-1199), the β-alanine benzyl ester conjugate (HS-1200) of CDCA, and HS-1183 induced apoptosis via a p53-independent pathway in human breast carcinoma cells . HS-1199 and HS-1200 also showed apoptotic activity in human leukemic T cells through the activation of caspases .
Cellular and biochemical effects of synthetic bile acids
Cell cycle arrest Synthetic bile acids play a novel role in regulating the cell cycle. In mammalian cells, D-type cyclins are synthesized during the G1 phase. They regulate G1/S transition with their partners, cdks (Nigg, 1995; Pines, 1995; Sherr and Roberts, 1995) . The cdk inhibitors regulate cellcycle progression by association with cyclin/cdk complexes (Fernandez et al., 1998; Hui et al., 1998) . The results from the immunoblotting analysis demonstrated that HS-1199 and/or HS-1200 selectively down-regulate the intracellular protein levels of D-type cyclins, which play essential roles as positive regulators of cdk4 and cdk6 activities. There was no change in the levels of cdks .
Moreover, the synthetic bile acids selectively induced the expression of the cdk inhibitor p21 WAF1/CIP1 without affecting the protein level of p53. They also increase the p21
WAF1/CIP1
protein that is tightly associated with cdk2 . These results demonstrated that the down-regulations of cdks and cyclin E-dependent kinase activities were mainly caused by the selective induction of the p21 WAF1/CIP1 expression. The effect of HS-1199 and HS-1200 was more distinct than that of HS-1183. Furthermore, the increased p21 WAF1/CIP1 protein by treatment with the synthetic bile acid derivatives was strongly associated with PCNA, which is required for the process of DNA synthesis by DNA polymerases (Li et al., 1994; Gibbs et al., 1997) . These results suggest that the synthetic bile acidinduced p21
WAF1/CIP1 could inhibit the PCNA function by direct binding to PCNA.
Apoptosis
The growth inhibitory effect of the synthetic bile acids was derived from the induction of apoptosis with several characteristic features. After exposure to synthetic bile acids, morphological changes in the nuclei were observed by nuclear staining with DAPI (Im et al., 1999) . As shown by a flow cytometry analysis, the sub G1 population of cells was increased by synthetic bile acids.
Apoptotic cell death by the synthetic bile acid derivatives was also confirmed by DNA ladder formation . It has been proposed that DNA fragmentation resulted from the loss of compartmentalization of DNase I, which would reach the nucleus due to the breakdown of the endoplasmic reticulum and the nuclear membrane (Fraser et al., 1996) . This cleavage produces ladders of DNA fragments that are the size of integer multiples of a nucleosome length (180-200 bp) (Huang et al., 1997) .
When cells undergo apoptosis, specific degradation of several proteins (such as lamin B and poly (ADP-ribose) polymerase (PARP), followed by internucleosomal DNA degradation) has been reported (Berger, 1985; Neamati et al., 1995) . PARP is an enzyme that is involved in DNA repair and genomic integrity, and used as a biochemical marker of chemotherapy-induced apoptosis, as mentioned previously (Cohen, 1997; Rosen and Casciola-Rosen, 1997; Konopleva et al., 1999) . A collapse of chromatin and nuclear structure in apoptosis is also consistent with the degradation of lamins, which are a part of the nuclear envelope (Oberhammer et al., 1994) . Cleavages of PARP and lamin B were shown by the treatment of the synthetic bile acid derivatives .
Several members of the caspase family, including caspase-3 and 8, have been identified as proteases, which cleave the PARP protein (Lazebnik et al., 1994) . Therefore, subsequent experiments addressed the issue of whether or not synthetic bile acid derivative-induced apoptosis was associated with caspase activation. The immunoblot analysis revealed that the steady-state levels of both procaspase-3 and procaspase-8 proteins were markedly decreased in cells that were treated with the synthetic bile acids . This suggests that the caspase-mediated signaling might contribute to the synthetic bile acid-mediated apoptosis in Jurkat cells. By comparison, CDCA and UDCA themselves did not affect the levels of caspase-3 or caspase-8 expressions. Furthermore, the apoptotic markers (including chromatin condensation, DNA ladder formation, and proteolytic cleavage of PARP) were completely prevented when the cells were pretreated with zVAD-fmk and DEVD-fmk, which is a broad-spectrum inhibitor of caspases and a specific inhibitor of caspase-3 , respectively.
The Bcl-2 oncoprotein, and other related proteins, might play an important role in determining whether cells undergo apoptosis. The increased expression of Bax can induce apoptosis by suppressing the activity of Bcl-2 (Findley et al., 1997) . It was also reported that the ratio of Bcl-2 to Bax, rather than Bcl-2 alone, was more important for the survival of drug-induced apoptosis (Salomons et al., 1997) . Although the Bcl-2 expression was not significantly changed in MCF-7 cells that were treated with the synthetic bile acid derivatives, there was a significant increase of the Bax expression ). Additionally, the expression level of Bax was increased and that of Bcl-2 was markedly decreased in MDA-MB-231 cells . Therefore, the increased ratio of Bax to Bcl-2 might contribute to the initiation of apoptosis in the synthetic bile acid-treated cells.
In apoptosis, cytosolic Ca 2+ affects the mitochondrial permeability transition pore complex directly, and induces the rupture of the outer membrane of mitochondria (Bernardi and Petronilli, 1996) . The elevation of Ca 2+ also induces the release of caspase-activating proteins (Li et al., 2000) . A Ca 2+ chelator, BAPTA/AM, was pre-treated to cells before the HS-1200 (25 µM) treatment in MCF-7 cells (Im, E.O. and Kim, N.D., unpublished data) . However, the BAPTA/AM cotreatment could not block the synthetic bile acid derivatives induced apoptosis, and it also slightly potentiated apoptosis induction. Therefore, Ca 2+ did not act as a signaling molecule in the synthetic bile acid-induced apoptosis.
Alterations in mitochondrial function
Alterations in the mitochondrial function in general, and induction of the mitochondrial permeability transition (MPT), play a key part in the regulation of apoptosis (Kroemer et al., 1997; Green and Reed, 1998; Susin et al., 1999) . Moreover, antioxidants and blockers of the mitochondrial permeability transition inhibited the hydrophobic bile acid-induced rat hepatocyte apoptosis (Yerushalmi et al., 2001) . The mitochondrial membrane potential (∆Ψm) can be monitored in living cells using numerous potentially sensitive dyes. With the use of these dyes, the ∆Ψm dissipates before the plasma membrane disrupts, not only in apoptosis but also in numerous in vitro models of necrosis (Kroemer et al., 1998) . Synthetic bile acid derivatives induced loss of ∆Ψm in human retinal pigment epithelial cells (Yoon et al., 2001) .
Mechanism of action of synthetic bile acid in apoptosis
Although the detailed molecular mechanism of the induction of apoptosis by the synthetic bile acids is still unknown, it can be speculated that the possible mechanism is based on the data of previous studies with natural bile acids (Fig. 2) . Bile salt cytotoxicity, both in vivo and in vitro, was mediated by the death receptor Fas (Faubion et al., 1999; Miyoshi et al., 1999) .
GCDC induced Fas oligomerization and activated caspase-8, resulting in apoptosis, independently of Fas ligand (Faubion et al., 1999) in rodent hepatocyte. Another study demonstrated that enhanced PI3K activity inhibited the Fas-mediated apoptosis (Cristofano et al., 1999) . Thus, the bile acid-induced Fas activation appears to be inhibited by the simultaneous activation of a kinase-dependent, anti-apoptotic signaling pathway that blocks the cytotoxicity of bile acids. The taurine conjugate of CDCA, TCDC, activates a PI3K survival pathway that blocks the inherent toxicity of GCDC (Rust et al., 2000) . NF-κB is one of the downstream targets of the TCDC stimulated PI3K activity. Thus, NF-κB may suppress the bile acid-mediated Fas/caspase-8 activation by upregulating antiapoptotic proteins, such as the inhibitor of the apoptosis protein-1 (cIAP-1) (Wang et al., 1996) . Therefore, we assume that the synthetic bile acids may induce apoptosis by activating the Fas receptor-signaling pathway.
Interestingly, there have been numerous reports that the PKC signaling pathway was involved in the effect of several bile acids. Bile acids can activate PKC directly in vitro and in vivo assays (Fitzer et al., 1987; Huang et al., 1992; Wali et al., 1995; Morgan et al., 1997; Qiao et al., 2000) , perhaps by substituting for phosphatidyl serine (Ward and OBrian, 1988) , and indirectly by stimulating the phospholipase C activity. This results in the increased production of diacylglycerol, a known co-factor that is required for PKC activation (Craven et al., 1987) . Therefore, it is possible that PKC might be a likely component of the mechanism by which the synthetic bile acids exert their biological effects.
We also presume that the synthetic bile acids, which have chemical structures that are similar to glucocorticoids, may directly affect the signaling molecules in cytosol by passing through the cell membrane. Moreover, it was recently reported that CDCA exerted its action by binding to an orphan nuclear receptor, FXR, as a natural ligand (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999; Song et al., 2001) . Similarly, the synthetic CDCA derivatives may bind FXR, or even possibly be a ligand for a co-activator/co-repressor type of molecule. Further experiments are open in the future to elucidate the structure/function relationship of the synthetic CDCA and UDCA derivatives.
Summary and implications
In this paper, we outlined the current understanding of natural and synthetic bile acid signaling in apoptosis. Much insight was gained in recent years, particularly with respect to the inducers of the hydrophobic bile acid signaling cascade. Moreover, the newly synthesized bile acids also induced apoptosis in several human cancer cells, which were not derived from hepatocytes, cholangiocytes, and ileal enterocytes. Therefore, the new synthetic bile acids might be applicable novel apoptosis mediators for the treatment of various cancer cells.
In human breast and prostate cancer cells with different tumor suppressor p53 status, the synthetic bile acid derivativeinduced growth inhibition and apoptosis were associated with the up-regulation of Bax and p21
WAF1/CIP1
, and the effects were mediated via a p53-inpendent pathway. In Jurkat human T cell leukemia, the synthetic bile acid derivatives induced apoptosis through caspase activation. Additionly, the synthetic bile acids induced apoptosis in a JNK dependent manner in SiHa human cervical cancer cells, PC3 prostate cancer cells, HT29 colon cancer cells, and TE671 brain tumor cells (Im, E.O., Yoo, Y.H., and Kim, N.D., unpublished data) .
Alterations in cell survival play a critical role for the pathogenesis of various human diseases, including cancer (Thompson, 1995) . Administration of modified bile acids that induce apoptosis might represent a rational therapy for tumors that originate from several different types of cells. Therefore, these novel derivatives of bile acids may represent promising chemical entities, which specifically target various cancer cells by triggering apoptosis. These could be important lead compounds for the development of new anticancer agents that are based on the structure of bile acids.
